H2-Eb2 | histocompatibility 2, class II antigen E beta2
Physiological systems
16 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Hematopoietic system
13 No significant impact
8 Not tested
Data collections
Gene metrics:3Significant phenotypes
15Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
increased circulating triglyceride level | 1 supporting dataset | H2-Eb2em1(IMPC)J | homozygote | Early adult | 7.99x10-5 | ||
decreased leukocyte cell number | 1 supporting dataset | H2-Eb2em1(IMPC)J | homozygote | Early adult | 5.08x10-5 | ||
thrombocytopenia | 1 supporting dataset | H2-Eb2em1(IMPC)J | homozygote | Early adult | 4.28x10-5 |
| | | | | | | | | |
External links
No external links available for H2-Eb2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
H2-Eb2em1(IMPC)J | Intra-exon deletion | | mouse |
H2-Eb2em1(IMPC)Wtsi | Deletion | | mouse |
H2-Eb2tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
H2-Eb2tm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |